Variant report
Variant | esv1830522 |
---|---|
Chromosome Location | chr22:23249220-23284600 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:924)
- CpG islands (count:0)
- Chromatin interactive region (count:56)
- LncRNA region (count:6)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr22:23258750-23259076 | HepG2 | liver: | n/a | n/a |
2 | ARID3A | chr22:23282059-23282441 | HepG2 | liver: | n/a | n/a |
3 | ATF1 | chr22:23251232-23251667 | K562 | blood: | n/a | n/a |
4 | ATF1 | chr22:23249632-23250275 | K562 | blood: | n/a | n/a |
5 | ATF1 | chr22:23254917-23254918 | K562 | blood: | n/a | n/a |
6 | ATF1 | chr22:23270547-23272244 | K562 | blood: | n/a | n/a |
7 | ATF1 | chr22:23262737-23263489 | K562 | blood: | n/a | n/a |
8 | ATF1 | chr22:23253446-23253456 | K562 | blood: | n/a | n/a |
9 | ATF1 | chr22:23279242-23279779 | K562 | blood: | n/a | n/a |
10 | ATF1 | chr22:23252055-23252437 | K562 | blood: | n/a | n/a |
11 | ATF1 | chr22:23266964-23266992 | K562 | blood: | n/a | n/a |
12 | ATF2 | chr22:23248892-23250514 | GM12878 | blood: | n/a | n/a |
13 | ATF2 | chr22:23273983-23274459 | GM12878 | blood: | n/a | n/a |
14 | ATF2 | chr22:23277251-23278348 | GM12878 | blood: | n/a | n/a |
15 | ATF2 | chr22:23277487-23278267 | GM12878 | blood: | n/a | n/a |
16 | ATF2 | chr22:23270597-23271768 | GM12878 | blood: | n/a | n/a |
17 | ATF2 | chr22:23273248-23273796 | GM12878 | blood: | n/a | n/a |
18 | ATF2 | chr22:23248930-23250295 | GM12878 | blood: | n/a | n/a |
19 | ATF2 | chr22:23270734-23271601 | GM12878 | blood: | n/a | n/a |
20 | ATF2 | chr22:23273903-23274587 | GM12878 | blood: | n/a | n/a |
21 | ATF3 | chr22:23268441-23268917 | K562 | blood: | n/a | chr22:23268625-23268635 |
22 | ATF3 | chr22:23284481-23286273 | K562 | blood: | n/a | n/a |
23 | ATF3 | chr22:23270541-23271262 | K562 | blood: | n/a | n/a |
24 | BACH1 | chr22:23279302-23279479 | H1-hESC | embryonic stem cell: | n/a | n/a |
25 | BACH1 | chr22:23265361-23265362 | K562 | blood: | n/a | n/a |
26 | BACH1 | chr22:23259715-23259720 | K562 | blood: | n/a | n/a |
27 | BACH1 | chr22:23261304-23261342 | K562 | blood: | n/a | n/a |
28 | BATF | chr22:23277686-23278091 | GM12878 | blood: | n/a | n/a |
29 | BATF | chr22:23274036-23274442 | GM12878 | blood: | n/a | n/a |
30 | BATF | chr22:23277663-23278179 | GM12878 | blood: | n/a | n/a |
31 | BATF | chr22:23270779-23271374 | GM12878 | blood: | n/a | chr22:23271120-23271130 chr22:23271115-23271126 chr22:23271116-23271126 |
32 | BATF | chr22:23270934-23271250 | GM12878 | blood: | n/a | chr22:23271120-23271130 chr22:23271115-23271126 chr22:23271116-23271126 |
33 | BCL11A | chr22:23277591-23278142 | GM12878 | blood: | n/a | chr22:23277928-23277937 |
34 | BCL11A | chr22:23274000-23274473 | GM12878 | blood: | n/a | chr22:23274243-23274252 |
35 | BCL11A | chr22:23277590-23278282 | GM12878 | blood: | n/a | chr22:23277928-23277937 |
36 | BCL11A | chr22:23247624-23250417 | GM12878 | blood: | n/a | chr22:23248333-23248341 |
37 | BCL11A | chr22:23274059-23274393 | GM12878 | blood: | n/a | chr22:23274243-23274252 |
38 | BCL11A | chr22:23270716-23271416 | GM12878 | blood: | n/a | chr22:23271010-23271019 |
39 | BCL11A | chr22:23270885-23271275 | GM12878 | blood: | n/a | chr22:23271010-23271019 |
40 | BCL3 | chr22:23277522-23278255 | GM12878 | blood: | n/a | chr22:23277928-23277937 |
41 | BCL3 | chr22:23274032-23274445 | GM12878 | blood: | n/a | chr22:23274243-23274252 |
42 | BCL3 | chr22:23248947-23250094 | GM12878 | blood: | n/a | n/a |
43 | BCL3 | chr22:23270747-23271458 | GM12878 | blood: | n/a | chr22:23271010-23271019 |
44 | BCL3 | chr22:23273934-23274465 | GM12878 | blood: | n/a | chr22:23274243-23274252 |
45 | BCL3 | chr22:23248989-23250139 | GM12878 | blood: | n/a | n/a |
46 | BCL3 | chr22:23277565-23278131 | GM12878 | blood: | n/a | chr22:23277928-23277937 |
47 | BCLAF1 | chr22:23248885-23250608 | GM12878 | blood: | n/a | n/a |
48 | BCLAF1 | chr22:23248919-23250395 | GM12878 | blood: | n/a | n/a |
49 | BCLAF1 | chr22:23273701-23274572 | GM12878 | blood: | n/a | chr22:23274243-23274252 chr22:23274497-23274505 |
50 | BCLAF1 | chr22:23270454-23271872 | GM12878 | blood: | n/a | chr22:23271010-23271019 |
No data |
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr22:23211923..23213773-chr22:23255638..23258101,2 | K562 | blood: | |
2 | chr22:22819406..22819970-chr22:23284540..23285372,2 | K562 | blood: | |
3 | chr22:23269159..23271034-chr22:23285763..23287373,2 | K562 | blood: | |
4 | chr22:23234328..23239223-chr22:23249114..23253993,6 | K562 | blood: | |
5 | chr22:23261117..23263641-chr22:23264707..23267231,3 | K562 | blood: | |
6 | chr22:23175251..23177707-chr22:23277255..23279235,2 | K562 | blood: | |
7 | chr22:23258677..23261321-chr22:23267871..23270694,4 | K562 | blood: | |
8 | chr22:23245468..23247565-chr22:23249258..23251335,3 | K562 | blood: | |
9 | chr22:23269604..23273139-chr22:23273414..23276481,4 | K562 | blood: | |
10 | chr22:23269604..23273139-chr22:23273414..23276481,4 | K562 | blood: | |
11 | chr22:23225282..23228590-chr22:23283687..23286029,3 | K562 | blood: | |
12 | chr22:23249788..23251920-chr22:23270655..23273406,3 | K562 | blood: | |
13 | chr22:23246871..23249530-chr22:23253643..23256082,2 | K562 | blood: | |
14 | chr22:23257526..23260347-chr22:23270856..23273684,2 | MCF-7 | breast: | |
15 | chr22:23266292..23268666-chr22:23279796..23283281,3 | K562 | blood: | |
16 | chr22:23195451..23196440-chr22:23280544..23281196,2 | K562 | blood: | |
17 | chr22:23251853..23252558-chr22:23295506..23296354,3 | MCF-7 | breast: | |
18 | chr22:23219235..23219863-chr22:23270722..23271390,2 | K562 | blood: | |
19 | chr22:23236796..23239209-chr22:23258890..23261514,2 | K562 | blood: | |
20 | chr22:23248970..23251030-chr22:23266059..23268328,2 | K562 | blood: | |
21 | chr22:23281421..23283891-chr22:23290438..23292257,2 | K562 | blood: | |
22 | chr22:23183438..23186320-chr22:23270023..23271683,2 | K562 | blood: | |
23 | chr22:23152432..23153103-chr22:23254207..23254852,2 | K562 | blood: | |
24 | chr22:23283138..23284821-chr22:23521700..23523896,2 | K562 | blood: | |
25 | chr22:23225869..23226888-chr22:23284493..23285611,4 | K562 | blood: | |
26 | chr22:23230851..23232657-chr22:23258084..23260097,2 | K562 | blood: | |
27 | chr22:23270409..23272197-chr22:23283086..23285103,2 | K562 | blood: | |
28 | chr22:23248970..23251030-chr22:23266059..23268328,2 | K562 | blood: | |
29 | chr22:23249849..23250456-chr22:23284637..23285518,2 | K562 | blood: | |
30 | chr22:23254052..23256994-chr22:23268482..23271052,2 | K562 | blood: | |
31 | chr22:23231973..23234722-chr22:23268972..23271345,2 | MCF-7 | breast: | |
32 | chr22:23176207..23178298-chr22:23277735..23280174,2 | K562 | blood: | |
33 | chr22:23283899..23288368-chr22:23289284..23293076,7 | K562 | blood: | |
34 | chr22:23126814..23129799-chr22:23281583..23283396,2 | K562 | blood: | |
35 | chr22:23249788..23251920-chr22:23270655..23273406,3 | K562 | blood: | |
36 | chr22:23190337..23191135-chr22:23277615..23278474,2 | K562 | blood: | |
37 | chr22:23276558..23279492-chr22:23287483..23289358,2 | K562 | blood: | |
38 | chr22:23263458..23265124-chr22:23267456..23270407,2 | K562 | blood: | |
39 | chr22:23258107..23260177-chr22:23268082..23270661,2 | K562 | blood: | |
40 | chr22:23258107..23260177-chr22:23268082..23270661,2 | K562 | blood: | |
41 | chr22:23271545..23273567-chr22:23289644..23291552,2 | K562 | blood: | |
42 | chr22:23249460..23256264-chr22:23263399..23267410,8 | K562 | blood: | |
43 | chr22:23266292..23268666-chr22:23279796..23283281,3 | K562 | blood: | |
44 | chr22:23249460..23256264-chr22:23263399..23267410,8 | K562 | blood: | |
45 | chr22:23261255..23263406-chr22:23270232..23272923,2 | MCF-7 | breast: | |
46 | chr22:23262831..23264788-chr22:23270674..23273625,2 | K562 | blood: | |
47 | chr22:23270409..23272197-chr22:23283086..23285103,2 | K562 | blood: | |
48 | chr22:23262649..23264269-chr22:23275725..23277382,2 | K562 | blood: | |
49 | chr22:23283899..23286228-chr22:23288836..23291377,2 | K562 | blood: | |
50 | chr22:23283587..23284135-chr22:23298210..23298770,2 | K562 | blood: |
(count:6 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RTDR1-4 | chr22:23264978-23265153 | NONHSAT083834 |
2 | lnc-RTDR1-4 | chr22:23261700-23261973 | NONHSAT083834 |
3 | lnc-D87017.1-2 | chr22:23257805-23258097 | NONHSAT083836 |
4 | lnc-RTDR1-4 | chr22:23262147-23262154 | NONHSAT083834 |
5 | lnc-D87017.1-3 | chr22:23252998-23253245 | NONHSAT083835 |
6 | lnc-RTDR1-4 | chr22:23264861-23264965 | NONHSAT083834 |
No data |
No data |
Variant related genes | Relation type |
---|---|
IGLJ5 | TF binding region |
IGLC7 | TF binding region |
IGLJ7 | TF binding region |
IGLJ6 | TF binding region |
IGLJ4 | TF binding region |
IGLC4 | TF binding region |
IGLC5 | TF binding region |
IGLC6 | TF binding region |
ENSG00000211680 | chromatin interactions |
ENSG00000186716 | chromatin interactions |
ENSG00000211684 | chromatin interactions |
ENSG00000211655 | chromatin interactions |
ENSG00000236794 | chromatin interactions |
ENSG00000211678 | chromatin interactions |
ENSG00000211679 | chromatin interactions |
ENSG00000221069 | chromatin interactions |
ENSG00000211674 | chromatin interactions |
ENSG00000264824 | chromatin interactions |
ENSG00000211672 | chromatin interactions |
ENSG00000211675 | chromatin interactions |
ENSG00000237127 | chromatin interactions |
ENSG00000211681 | chromatin interactions |
ENSG00000254029 | chromatin interactions |
ENSG00000222037 | chromatin interactions |
ENSG00000211682 | chromatin interactions |
ENSG00000254030 | chromatin interactions |
ENSG00000211685 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs371967544 | chr22:23249244-23249245 | Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
2 | rs527948750 | chr22:23249276-23249277 | Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
3 | rs144114443 | chr22:23249297-23249298 | Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
4 | rs367889784 | chr22:23249310-23249311 | Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
5 | rs188438900 | chr22:23249326-23249327 | Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
6 | rs361597 | chr22:23249349-23249350 | Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
7 | rs539487232 | chr22:23249350-23249351 | Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
8 | rs2519501 | chr22:23249354-23249355 | Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
9 | rs459830 | chr22:23249369-23249370 | Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
10 | rs570094978 | chr22:23249384-23249385 | Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
11 | rs2856875 | chr22:23249390-23249391 | Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
12 | rs555509816 | chr22:23249401-23249402 | Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
13 | rs146026811 | chr22:23249408-23249409 | Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
14 | rs541320094 | chr22:23249410-23249411 | Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
15 | rs558125639 | chr22:23249413-23249414 | Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
16 | rs180890383 | chr22:23249426-23249427 | Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
17 | rs543393762 | chr22:23249435-23249436 | Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
18 | rs2856876 | chr22:23249440-23249441 | Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 5 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs60702464 | chr22:23249443-23249444 | Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 5 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs542376531 | chr22:23249482-23249483 | Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
21 | rs184259617 | chr22:23249507-23249508 | Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
22 | rs2856877 | chr22:23249522-23249523 | Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
23 | rs2856878 | chr22:23249524-23249525 | Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
24 | rs527914915 | chr22:23249525-23249526 | Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
25 | rs571038330 | chr22:23249537-23249538 | Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
26 | rs547673041 | chr22:23249543-23249544 | Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
27 | rs139995153 | chr22:23249546-23249547 | Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
28 | rs533455521 | chr22:23249561-23249562 | Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
29 | rs550115625 | chr22:23249575-23249576 | Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
30 | rs143498039 | chr22:23249594-23249595 | Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
31 | rs190471698 | chr22:23249646-23249647 | Genic enhancers Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
32 | rs535923280 | chr22:23249647-23249648 | Genic enhancers Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
33 | rs182253060 | chr22:23249656-23249657 | Genic enhancers Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
34 | rs568738135 | chr22:23249675-23249676 | Genic enhancers Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
35 | rs186002392 | chr22:23249692-23249693 | Genic enhancers Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
36 | rs190417932 | chr22:23249698-23249699 | Genic enhancers Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
37 | rs557989857 | chr22:23249699-23249700 | Genic enhancers Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
38 | rs536178583 | chr22:23249700-23249701 | Genic enhancers Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
39 | rs577967923 | chr22:23249703-23249704 | Genic enhancers Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
40 | rs533334689 | chr22:23249720-23249721 | Genic enhancers Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
41 | rs962260 | chr22:23249721-23249722 | Genic enhancers Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
42 | rs112233840 | chr22:23249733-23249734 | Genic enhancers Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
43 | rs185442888 | chr22:23249737-23249738 | Genic enhancers Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
44 | rs542691205 | chr22:23249744-23249745 | Genic enhancers Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
45 | rs559223416 | chr22:23249747-23249748 | Genic enhancers Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
46 | rs117833187 | chr22:23249752-23249753 | Genic enhancers Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
47 | rs541179688 | chr22:23249823-23249824 | Enhancers Strong transcription Weak transcription | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
48 | rs564356656 | chr22:23249832-23249833 | Enhancers Strong transcription Weak transcription | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
49 | rs564373970 | chr22:23249838-23249839 | Enhancers Strong transcription Weak transcription | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
50 | rs550235214 | chr22:23249849-23249850 | Enhancers Strong transcription Weak transcription | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Velocardiofacial syndrome | 20111667 | CNVD |
Medulloblastoma | 21979893 | CNVD |
sporadic solitary meningiomas | 19589153 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Autism | 22495311 | CNVD |
Emanuel syndrome | 21549014 | CNVD |
Digeorge syndrome | 22283845 | CNVD |
Schizophrenia | 17504246 | CNVD |
Digeorge syndrome | 18033723 | CNVD |
22q11 deletion syndrome | 17034021 | CNVD |
22q11 deletion syndrome | 22511897 | CNVD |
22q11 deletion syndrome | 16829213 | CNVD |
Autism | 22067053 | CNVD |
Autism | 19218893 | CNVD |
Biliary cancer | 22067053 | CNVD |
Congenital heart defect | 21390462 | CNVD |
Digeorge syndrome | 16617304 | CNVD |
Emanuel syndrome | 18184694 | CNVD |
Non-syndromic sensorineural hearing loss | 18184694 | CNVD |
Obsessive-compulsive disorder | 22067053 | CNVD |
Psychosis | 22067053 | CNVD |
Schizophrenia | 19415332 | CNVD |
Schizophrenia | 20587603 | CNVD |
Shprintzen syndrome | 19443537 | CNVD |
absent pulmonary valve syndrome | 16795129 | CNVD |
language delay | 22067053 | CNVD |
periventricular nodular heterotopia | 20648244 | CNVD |
renal disease | 17924346 | CNVD |
Schizophrenia | 20433910 | CNVD |
22q11 deletion syndrome | 17028864 | CNVD |
Schizophrenia | 16969581 | CNVD |
Non-syndromic sensorineural hearing loss | 17135275 | CNVD |
velo-cardio-facial syndrome | 17135275 | CNVD |
Digeorge syndrome | 18787571 | CNVD |
Autism | 18925931 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
22q11.2 microdeletion syndrome | 21547621 | CNVD |
Congenital heart defect | 21308838 | CNVD |
Digeorge syndrome | 16512914 | CNVD |
Digeorge syndrome | 20954168 | CNVD |
Nuchal translucency | 21837766 | CNVD |
Right aortic arch in the fetus | 17066500 | CNVD |
Shprintzen syndrome | 17117043 | CNVD |
Tetralogy of fallot | 17405110 | CNVD |
Velocardiofacial syndrome | 20140301 | CNVD |
Velocardiofacial syndrome | 16512914 | CNVD |
bone mass and metabolism | 20516202 | CNVD |
choanal atresia | 18209138 | CNVD |
extracardiac malformations | 17086578 | CNVD |
fetal heart defects | 21308838 | CNVD |
parathyroid gland dysfunction | 16793949 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
velopharyngeal insufficiency | 19620585 | CNVD |
Prader-willi syndrome | 20942916 | CNVD |
22q11 deletion syndrome | 17653112 | CNVD |
Chronic myelomonocytic leukemia | 16760666 | CNVD |
Non-syndromic sensorineural hearing loss | 16829213 | CNVD |
Non-syndromic sensorineural hearing loss | 16760666 | CNVD |
Chordoma | 21602918 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Congenital heart defect | 22511896 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Seminomas | 18059402 | CNVD |
Cancer | 16751803 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Metachromatic leukodystrophy | 18421352 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Breast cancer | 21858162 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cat eye syndrome | 21549014 | CNVD |
Digeorge syndrome | 21549014 | CNVD |
22q11.2 microdeletion syndrome | 22051516 | CNVD |
22q11.2 microdeletion syndrome | 18483005 | CNVD |
22q11.2 microdeletion syndrome | 19565140 | CNVD |
22q11.2 microdeletion syndrome | 20396437 | CNVD |
22q11.2 microdeletion syndrome | 21390462 | CNVD |
22q11.2 microdeletion syndrome | 21573985 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 20970697 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Congenital heart defect | 21257016 | CNVD |
Developmental delay | 18414209 | CNVD |
DiGeorge-Velo cardiofacial | 19284877 | CNVD |
Epilepsy | 20970697 | CNVD |
Heart disease | 20551144 | CNVD |
Hughes'' syndrome | 16595601 | CNVD |
Mental retardation | 18414209 | CNVD |
Okamoto syndrome | 19046188 | CNVD |
Primary immunodeficiency | 22566803 | CNVD |
Schizophrenia | 20877625 | CNVD |
Schizophrenia | 20553308 | CNVD |
Schizophrenia | 21956041 | CNVD |
Schizophrenia | 20970697 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Velocardiofacial syndrome | 17556857 | CNVD |
Velocardiofacial syndrome | 20206275 | CNVD |
Velocardiofacial syndrome | 20970697 | CNVD |
delayed speech development | 21274400 | CNVD |
velo-cardio-facial syndrome | 16511839 | CNVD |
velo-cardio-facial syndrome | 21763005 | CNVD |
22q11.2 microdeletion syndrome | 18799940 | CNVD |
Digeorge syndrome | 20877625 | CNVD |
22q11.2 microdeletion syndrome | 18923514 | CNVD |
Congenital heart defect | 22185286 | CNVD |
DiGeorge-Velo cardiofacial | 16773131 | CNVD |
Digeorge syndrome | 20186050 | CNVD |
velo-cardio-facial conotruncal-face syndrome | 20186050 | CNVD |
22q11.2 microdeletion syndrome | 22116936 | CNVD |
Disorders of sex development | 22290220 | CNVD |
22q11.2 duplication syndrome | 18923514 | CNVD |
Autism | 22095694 | CNVD |
Mental retardation | 19951919 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Mental retardation | 16773131 | CNVD |
22q11.2 microdeletion syndrome | 22395003 | CNVD |
22q11.2 microdeletion syndrome | 18691436 | CNVD |
22q11.2 microdeletion syndrome | 18053182 | CNVD |
22q11.2 microdeletion syndrome | 18324686 | CNVD |
22q11.2 microdeletion syndrome | 20074913 | CNVD |
Congenital heart defect | 20802965 | CNVD |
Congenital heart defect | 21134246 | CNVD |
DiGeorge syndrome | 19040613 | CNVD |
DiGeorge-Velo cardiofacial | 18179902 | CNVD |
Digeorge syndrome | 18172682 | CNVD |
Digeorge syndrome | 22470819 | CNVD |
Digeorge syndrome | 21364285 | CNVD |
Neuroendocrine carcinoma | 22470819 | CNVD |
Non-syndromic sensorineural hearing loss | 20069674 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Tetralogy of fallot | 19144126 | CNVD |
Velo-cardio-facial syndrome | 21364285 | CNVD |
Velocardiofacial syndrome | 18788013 | CNVD |
cardiac malformation | 20573211 | CNVD |
cardiac malformation | 18172682 | CNVD |
velo-cardio-facial syndrome | 18636631 | CNVD |
Schizophrenia | 21822266 | CNVD |
synaptic plasticity | 21368174 | CNVD |
Schizophrenia | 18043741 | CNVD |
sporadic birth defects | 19047251 | CNVD |
Autism | 19046189 | CNVD |
DiGeorge-Velo cardiofacial | 19047251 | CNVD |
Hypernasal speech | 21968682 | CNVD |
Mental retardation | 17339581 | CNVD |
diverse phenotype | 16760730 | CNVD |
Mental retardation | 20152051 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Ovarian cancer | 22174824 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
DiGeorge-Velo cardiofacial | 17597781 | CNVD |
Digeorge syndrome | 17576883 | CNVD |
Schizophrenia | 18806272 | CNVD |
Schizophrenia | 18990708 | CNVD |
Velocardiofacial syndrome | 17576883 | CNVD |
Schizophrenia | 20075378 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Neuropsychiatric disorder | 20069037 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Emphysema | 19352772 | CNVD |
Cancer | 17440070 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Disease | 21346257 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Developmental delay | 21147756 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Asthma | 21956041 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
22q11.23 microdeletion syndrome | 19193630 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Autism | 20841430 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21785460 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ependymoma | 20639864 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Schizophrenia | 17989066 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr22:23247400-23249800 | Weak transcription | Right Atrium | heart |
2 | chr22:23247600-23251800 | Weak transcription | Dnd41 | blood |
3 | chr22:23249000-23249400 | Flanking Active TSS | Primary B cells from cord blood | blood |
4 | chr22:23249000-23249400 | Flanking Active TSS | GM12878-XiMat | blood |
5 | chr22:23249000-23249600 | Transcr. at gene 5' and 3' | Primary B cells from peripheral blood | blood |
6 | chr22:23249400-23249600 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin01 | Skin |
7 | chr22:23249400-23249800 | Genic enhancers | Primary B cells from cord blood | blood |
8 | chr22:23249400-23250800 | Enhancers | GM12878-XiMat | blood |
9 | chr22:23249600-23249800 | Genic enhancers | Primary B cells from peripheral blood | blood |
10 | chr22:23249800-23250600 | Enhancers | Primary B cells from cord blood | blood |
11 | chr22:23249800-23258400 | Enhancers | Primary B cells from peripheral blood | blood |
12 | chr22:23249800-23270800 | Strong transcription | Right Atrium | heart |
13 | chr22:23250600-23251800 | Weak transcription | Primary B cells from cord blood | blood |
14 | chr22:23250800-23251800 | Weak transcription | GM12878-XiMat | blood |
15 | chr22:23251800-23254000 | Enhancers | Dnd41 | blood |
16 | chr22:23251800-23254000 | Enhancers | GM12878-XiMat | blood |
17 | chr22:23251800-23256400 | Enhancers | Primary B cells from cord blood | blood |
18 | chr22:23252000-23252400 | Enhancers | Primary monocytes fromperipheralblood | blood |
19 | chr22:23252200-23253000 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
20 | chr22:23252200-23253000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
21 | chr22:23252400-23252600 | Enhancers | Fetal Thymus | thymus |
22 | chr22:23252400-23252600 | Bivalent Enhancer | Stomach Smooth Muscle | stomach |
23 | chr22:23252400-23256400 | Weak transcription | Primary monocytes fromperipheralblood | blood |
24 | chr22:23253000-23253200 | Enhancers | Spleen | Spleen |
25 | chr22:23253000-23253600 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
26 | chr22:23253000-23256200 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
27 | chr22:23253200-23253800 | Weak transcription | Spleen | Spleen |
28 | chr22:23253600-23253800 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
29 | chr22:23253600-23253800 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
30 | chr22:23253800-23254000 | Enhancers | Spleen | Spleen |
31 | chr22:23253800-23255800 | Weak transcription | Fetal Thymus | thymus |
32 | chr22:23253800-23256000 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
33 | chr22:23254000-23255200 | Weak transcription | Dnd41 | blood |
34 | chr22:23254000-23256000 | Weak transcription | GM12878-XiMat | blood |
35 | chr22:23254000-23268800 | Weak transcription | Spleen | Spleen |
36 | chr22:23254800-23255000 | Enhancers | HSMMtube | muscle |
37 | chr22:23255200-23256000 | Enhancers | Dnd41 | blood |
38 | chr22:23255200-23256400 | Weak transcription | HSMMtube | muscle |
39 | chr22:23255200-23257800 | Enhancers | Fetal Muscle Leg | muscle |
40 | chr22:23255400-23259400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
41 | chr22:23255800-23256800 | Enhancers | Primary hematopoietic stem cells | blood |
42 | chr22:23255800-23256800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
43 | chr22:23255800-23257200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
44 | chr22:23255800-23257400 | Enhancers | Fetal Thymus | thymus |
45 | chr22:23256000-23256800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
46 | chr22:23256000-23257000 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
47 | chr22:23256000-23257200 | Flanking Active TSS | Dnd41 | blood |
48 | chr22:23256000-23257800 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
49 | chr22:23256000-23257800 | Enhancers | GM12878-XiMat | blood |
50 | chr22:23256200-23256800 | Enhancers | Monocytes-CD14+_RO01746 | blood |